According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
The assay’s significant limitation is its inability to assess drug resistance for integrase inhibitors, including ...
An optimised reverse transcriptase assay detected very low HIV viral loads and phenotypic drug resistance in around 2 hours.
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect ...
A single laboratory-based HIV viral load test used by U.S. clinicians who provide people with long-acting, injectable cabotegravir (CAB-LA) HIV pre-exposure prophylaxis (PrEP) did not reliably detect ...
Next-day HIV viral load testing results do not significantly improve linkage to treatment or prevention care for adults at risk for acquisition or people with HIV not receiving daily antiretroviral ...
According to the U.S. Centers for Disease Control and Prevention (CDC) and other sources, there are approximately 1.2 million people living with HIV in the United States, and another 1.2 to 2.2 ...
Viral load monitoring has become the cornerstone of contemporary HIV care, providing a direct measure of antiretroviral therapy (ART) efficacy by quantifying plasma HIV RNA. Regular assessment of ...
Faith, 23, is on the verge of despair after being unable to check her HIV viral load for the second time this year. "Since they drew blood to test the viral load in January, the next time I was to be ...
Nearly 400,000 people living with HIV in Kenya did not receive a viral load test in the final quarter of 2025, new data shows, a gap that could allow undetected treatment failures to silently ...
The once-weekly tablet combines Merck's islatravir & Gilead's lenacapavir. The combo could become first complete once-weekly ...
A federally funded clinical trial suggests knowing HIV viral load (number of HIV particles in the body) doesn’t improve the number of patients seeking treatment for active HIV infection or preventive ...